CRUCELL HOLLAND B.V.
Patent Owner
Stats
- 162 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Apr 04, 2017 most recent publication
Details
- 162 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 5,390 Total Citation Count
- Aug 15, 1995 Earliest Filing
- 89 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9611317 Human binding molecules capable of neutralizing influenza virus H3N2 and uses thereofMay 20, 13Apr 04, 17[A61K, C12Q, C07K]
9428572 Human binding molecules having killing activity against enterococciDec 10, 13Aug 30, 16[A61K, C12P, G01N, C07K]
9428768 Method for the production and purification of adenoviral vectorsOct 28, 09Aug 30, 16[A61K, C12Q, C12N]
9403900 Anti-human respiratory syncytial virus (RSV) antibodies and methods of useJun 05, 14Aug 02, 16[A61K, C12N, G01N, C07K]
9365638 Antibodies against human respiratory syncytial virus (RSV) and methods of useSep 10, 13Jun 14, 16[C07H, C07K]
9200064 Human binding molecules capable of binding to and neutralizing influenza B viruses and uses thereofOct 13, 14Dec 01, 15[A61K, C12Q, G01N, C07K]
9168292 Heterologous prime boost vaccination regimen against malariaSep 07, 11Oct 27, 15[F16K, A61K, C12N]
9139642 Anti-human respiratory syncytial virus (RSV) antibodies and methods of useJul 08, 11Sep 22, 15[A61K, C12N, G01N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0002,318 HUMAN BINDING MOLECULES CAPABLE OF BINDING TO AND NEUTRALIZING INFLUENZA B VIRUSES AND USES THEREOFAbandonedSep 17, 15Jan 07, 16[A61K, G01N, C07K]
2014/0342,446 PNEUMATIC ALTERNATING PRESSURE MEMBRANE CELL SEPARATION SYSTEMAbandonedMay 22, 14Nov 20, 14[B01D]
2014/0322,264 THERAPEUTIC VACCINATION AGAINST ACTIVE TUBERCULOSISAbandonedJun 10, 14Oct 30, 14[A61K]
2013/0273,106 PRODUCTION OF POLIOVIRUS AT HIGH TITERS FOR VACCINE PRODUCTIONAbandonedMar 15, 13Oct 17, 13[C12N]
2013/0122,038 HETEROLOGOUS PRIME-BOOST IMMUNIZATION USING MEASLES VIRUS-BASED VACCINESAbandonedNov 13, 12May 16, 13[A61K]
2013/0052,224 PRODUCTION OF POLIOVIRUS AT HIGH TITERS FOR VACCINE PRODUCTIONAbandonedOct 25, 12Feb 28, 13[A61K, C12N, A61P]
2012/0315,696 METHOD FOR THE PRODUCTION OF Ad26 ADENOVIRAL VECTORSAbandonedFeb 14, 11Dec 13, 12[C12N, C12M]
8268966 Binding molecules for the treatment of myeloid cell malignanciesExpiredDec 18, 09Sep 18, 12[C12N, C07K]
2011/0159,543 SCALABLE PROCESS FOR CULTURING PER.C6 CELLS AND PRODUCING PRODUCTS THEREFROMAbandonedJul 09, 09Jun 30, 11[C12P, C12N]
7777010 Use of a native epitope for selecting evolved binding members from a library of mutants of a protein capable of binding to said epitopeExpiredJun 28, 02Aug 17, 10[C12P, C07K]
2010/0172,917 Binding molecules against SARS-coronavirus and uses thereofAbandonedNov 16, 09Jul 08, 10[A61K, C07H, C12Q, C12P, C12N, A61P, C40B, C07K]
2010/0143,302 Recombinant Adenoviruses Based on Serotype 26 and 48, and Use ThereofAbandonedMar 15, 07Jun 10, 10[A61K, C07H, C12N, A61P]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
